Literature DB >> 22669942

Multiple substitutions of methionine 129 in human prion protein reveal its importance in the amyloid fibrillation pathway.

Sofie Nyström1, Rajesh Mishra, Simone Hornemann, Adriano Aguzzi, K Peter R Nilsson, Per Hammarström.   

Abstract

The role of the polymorphism Met or Val in position 129 in the human prion protein is well documented regarding disease susceptibility and clinical manifestations. However, little is known about the molecular background to this phenomenon. We investigated herein the conformational stability, amyloid fibrillation kinetics, and seeding propensity of different 129 mutants, located in β-strand 1 of PrP (Met(129) (WT), M129A, M129V, M129L, M129W, M129P, M129E, M129K, and M129C) in HuPrP(90-231). The mutations M129V, M129L, M129K, and M129C did not affect stability (midpoints of thermal denaturation, T(m) = 65-66 °C), whereas the mutants M129A and M129E and the largest side chain M129W were destabilized by 3-4 °C. The most destabilizing substitution was M129P, which lowered the T(m) by 7.2 °C. All mutants, except for M129C, formed amyloid-like fibrils within hours during fibril formation under near physiological conditions. Fibril-forming mutants showed a sigmoidal kinetic profile and showed shorter lag times during seeding with preformed amyloid fibrils implicating a nucleated polymerization reaction. In the spontaneous reactions, the lag time of fibril formation was rather uniform for the mutants M129A, M129V, and M129L resembling the wild type. When the substituted amino acid had a distinct feature discriminating it from the wild type, such as size (M129W), charge (M129E, M129K), or rotational constraint (M129P), the fibrillation was impeded. M129C did not form ThT/Congo red-positive fibrils, and non-reducing SDS-PAGE of M129C during fibrillation conditions at different time points revealed covalent dimer formation already 15 min after fibrillation reaction initiation. Position 129 appears to be a key site for dictating PrP receptiveness toward recruitment into the amyloid state.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22669942      PMCID: PMC3406681          DOI: 10.1074/jbc.M112.372136

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  61 in total

1.  van't Hoff enthalpies without baselines.

Authors:  D M John; K M Weeks
Journal:  Protein Sci       Date:  2000-07       Impact factor: 6.725

2.  An analytical solution to the kinetics of breakable filament assembly.

Authors:  Tuomas P J Knowles; Christopher A Waudby; Glyn L Devlin; Samuel I A Cohen; Adriano Aguzzi; Michele Vendruscolo; Eugene M Terentjev; Mark E Welland; Christopher M Dobson
Journal:  Science       Date:  2009-12-11       Impact factor: 47.728

3.  Inter-oligomer interactions of the human prion protein are modulated by the polymorphism at codon 129.

Authors:  Remo Gerber; Kislon Voitchovsky; Clement Mitchel; Abdessamad Tahiri-Alaoui; John F Ryan; P J Hore; William James
Journal:  J Mol Biol       Date:  2008-05-29       Impact factor: 5.469

4.  Heparin binding by murine recombinant prion protein leads to transient aggregation and formation of RNA-resistant species.

Authors:  Tuane C R G Vieira; Daniel P Reynaldo; Mariana P B Gomes; Marcius S Almeida; Yraima Cordeiro; Jerson L Silva
Journal:  J Am Chem Soc       Date:  2010-12-13       Impact factor: 15.419

5.  Increased susceptibility to Kuru of carriers of the PRNP 129 methionine/methionine genotype.

Authors:  H S Lee; P Brown; L Cervenáková; R M Garruto; M P Alpers; D C Gajdusek; L G Goldfarb
Journal:  J Infect Dis       Date:  2000-12-21       Impact factor: 5.226

Review 6.  Prion diseases of humans and animals: their causes and molecular basis.

Authors:  J Collinge
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

Review 7.  Prion diseases and their biochemical mechanisms.

Authors:  Nathan J Cobb; Witold K Surewicz
Journal:  Biochemistry       Date:  2009-03-31       Impact factor: 3.162

8.  Amyloid fibrils of human prion protein are spun and woven from morphologically disordered aggregates.

Authors:  Karin Almstedt; Sofie Nyström; K Peter R Nilsson; Per Hammarström
Journal:  Prion       Date:  2009-10-16       Impact factor: 3.931

9.  Crystal structure of human prion protein bound to a therapeutic antibody.

Authors:  S V Antonyuk; C R Trevitt; R W Strange; G S Jackson; D Sangar; M Batchelor; S Cooper; C Fraser; S Jones; T Georgiou; A Khalili-Shirazi; A R Clarke; S S Hasnain; J Collinge
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-09       Impact factor: 11.205

10.  Prion protein library of recombinant constructs for structural biology.

Authors:  Simone Hornemann; Barbara Christen; Christine von Schroetter; Daniel R Pérez; Kurt Wüthrich
Journal:  FEBS J       Date:  2009-04       Impact factor: 5.542

View more
  8 in total

1.  Reduced Lipid Bilayer Thickness Regulates the Aggregation and Cytotoxicity of Amyloid-β.

Authors:  Kyle J Korshavn; Cristina Satriano; Yuxi Lin; Rongchun Zhang; Mark Dulchavsky; Anirban Bhunia; Magdalena I Ivanova; Young-Ho Lee; Carmelo La Rosa; Mi Hee Lim; Ayyalusamy Ramamoorthy
Journal:  J Biol Chem       Date:  2017-02-01       Impact factor: 5.157

2.  Impact of methionine oxidation as an initial event on the pathway of human prion protein conversion.

Authors:  Mohammed I Y Elmallah; Uwe Borgmeyer; Christian Betzel; Lars Redecke
Journal:  Prion       Date:  2013-10-09       Impact factor: 3.931

3.  HSP10 as a Chaperone for Neurodegenerative Amyloid Fibrils.

Authors:  Johan N K Larsson; Sofie Nyström; Per Hammarström
Journal:  Front Neurosci       Date:  2022-06-13       Impact factor: 5.152

4.  PrionW: a server to identify proteins containing glutamine/asparagine rich prion-like domains and their amyloid cores.

Authors:  Rafael Zambrano; Oscar Conchillo-Sole; Valentin Iglesias; Ricard Illa; Frederic Rousseau; Joost Schymkowitz; Raimon Sabate; Xavier Daura; Salvador Ventura
Journal:  Nucleic Acids Res       Date:  2015-05-14       Impact factor: 16.971

5.  Generic amyloidogenicity of mammalian prion proteins from species susceptible and resistant to prions.

Authors:  Sofie Nyström; Per Hammarström
Journal:  Sci Rep       Date:  2015-05-11       Impact factor: 4.379

6.  Protein Structure and Biology: Poster Abstracts.

Authors: 
Journal:  Prion       Date:  2013 Apr/May       Impact factor: 3.931

7.  The A2V mutation as a new tool for hindering Aβ aggregation: A neutron and x-ray diffraction study.

Authors:  Laura Cantu'; Laura Colombo; Tatiana Stoilova; Bruno Demé; Hideyo Inouye; Rachel Booth; Valeria Rondelli; Giuseppe Di Fede; Fabrizio Tagliavini; Elena Del Favero; Daniel A Kirschner; Mario Salmona
Journal:  Sci Rep       Date:  2017-07-14       Impact factor: 4.379

8.  Lack of association of the M129V polymorphism of the PRNP gene with pseudoexfoliation syndrome.

Authors:  Marios P Giannakopoulos; Anna G Antonacopoulou; Anastasia E Kottorou; Haralabos P Kalofonos; Sotirios P Gartaganis
Journal:  Clin Ophthalmol       Date:  2016-04-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.